Nirav Dhanesha Shares The Lab’s Latest Publication on Neutrophil CD14 and DVT Link
Nirav Dhanesha, Assistant Professor at the Louisiana State University, shared on LinkedIn:
”Latest publication from our lab in Blood Advance, Blood Journals Portfolio
Beyond its common application as a lineage marker to identify monocytes in flow-cytometry assays, CD14 is highly expressed in neutrophils and serves as a functional driver of DVT.
In this study, we identifies neutrophil CD14 as a specific driver and therapeutic target for DVT.
CoreFindings:
Identification: Multiomic profiling (RNA-seq, proteomics, flow cytometry) reveals neutrophil CD14 overexpression within 3-hr of DVT onset.
Mechanism: Elevated plasma G-CSF drives this CD14 expression via the transcription factor C/EBPα.
InVivo Validation: Neutrophil-specific CD14 knockdown significantly reduces DVT severity.
Translational Relevance: In G-CSF-stimulated primary human neutrophils, CD14 inhibition reduces inflammation and NETosis.
These data establish the G-CSF/C/EBPα/CD14 axis as a primary mechanism in DVT pathogenesis and suggest CD14 as a viable site for therapeutic intervention.
Link of the paper.
Congratulations to the first authors, Nilesh Pandey and Harpreet Kaur, Ph.D., for their hard work and persistence.
Many thanks to all the collaborators and co-authors for their contributions to this work.”
Article: Neutrophil CD14 is a Driver and a Therapeutic Target for Deep Vein Thrombosis
Authors: Nilesh Pandey, Harpreet Kaur, Raktim Mitra, Lakshmi Chandaluri, Nirvana Shaaban, Alexa Martinez, Evan Kidder, Sumit Kumar Anand, Megan Butler, Xiaolu Zhang, Dweipayan Goswami, Louise Frausto, Dhananjay Kumar, Rajan Pandit, Sandeep Das, Sumati Rohilla, Suman Mohajan, Gurranna Male, Amdadul Huque, Amr R Salem, Tarek Magdy, David S Gross, Karen Y Stokes, A Wayne Orr, Sultan Tousif, Arif Yurdagul Jr, Oren Rom, Nirav Dhanesha
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 23, 2026, 15:36Simon Senanu: The Peripheral Blood Smear as an Essential Diagnostic Tool in Modern Medicine
-
Feb 23, 2026, 15:32Cheng-Hock Toh: The Paradox of Hematology
-
Feb 23, 2026, 15:20Rabab Al Dawood: Moderating the Coagulation and Hemostasis Session at the ISLH 1st Joint Conference
-
Feb 23, 2026, 15:16Amira Khater: Key Updates on Pulmonary Embolism Management from AHA and ACC Guidelines
-
Feb 23, 2026, 14:45Stacey McGeown: Rare Disease Awareness Day at QUB Marks the Start of Rare Disease Month
-
Feb 23, 2026, 13:53Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 1
-
Feb 23, 2026, 13:02Deepak Yadav: What 2025 Evidence Tells Us About Stroke Care
-
Feb 23, 2026, 12:55Radoslaw Kaczmarek: Will AAV Gene Therapy for Hemophilia Trigger Tumorigenesis?
-
Feb 23, 2026, 12:46Heghine Khachatryan: More Granular Risk Stratification Framework for PE from The New 2026 AHA/ACC Guideline